68Gallium-FAPI46 PET/CT Imaging in Chronic Inflammatory and Fibrotic Diseases
Recruiting
N/A
Interventional Study
Inflammatory Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 390 (estimated)
- Sponsor
- University Hospital, Brest · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This single-center pilot study is designed to explore the preliminary utility of the \[68Ga\] Ga-FAPI imaging agent in positron emission tomography (PET) combined with computed tomography (CT) for a range of chronic inflammatory and fibrosing diseases. The study focuses on the potential of \[68Ga\] Ga-FAPI, a novel radiotracer targeting Fibroblast Activation Protein (FAP), to improve diagnostic ac…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient aged 18 or over.
* Affected by one of the pathologies concerned by the study (see Table 4)
* Satisfying the consensus classification criteria for the pathology (Table 3).
* Satisfying the corresponding clinical situation (Table 3).
* Negative urine pregnancy test for w…
Contacts